Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Overview
- Initiating an immune response: the problem
- Naïve lymphocyte activation and function
- How do lymphocytes survey the body?
- Mobilisation from tissues to draining lymph nodes
- Naïve cells migrate through lymph nodes & spleen
- Lymphocyte homing is required to protect our body
- Lymphocyte homing controls cancer & autoimmunity
- Lymphocyte surveying dendritic cells in lymph nodes
- High endothelial venules (HEV)
- Lymphocyte migration pathways
- Effector T cell homing
- Lymphocyte recruitment from bloodstream to tissue
- Multistep adhesion cascade of lymphocyte recruitment
- Recruitment is regulated by the adhesion cascade
- Key events in T lymphocyte homing
- Homing associated Selectins, integrins and chemokines
- Homing addresses' direct migration of T cells
- Lymphocyte homing protects against influenza virus
- Why study lymphocyte homing?
- Summary: what we do and don't know
- Generating CD8+ T cell immunity to cancers
- T cell homing in the cancer-immunity cycle
- Tumour blood vessels are immature at recruiting T cells
- Evidence of immune response to solid cancers
- Adoptive T cell cancer therapy
- Designer T cell therapy for cancer
- Suggested reading
- Thank you for your attention
Topics Covered
- Naïve T & B cells homing to lymph nodes
- Effector T cell homing
- Lymphocyte migration pathways
- Key events and molecules in T lymphocyte homing
- Controlling cancer & autoimmunity through lymphocyte homing
- T cell homing in the cancer-immunity cycle
- Designer T cell therapy for cancer
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Ager, A. (2020, October 29). Lymphocyte homing: getting lymphocytes to the right place at the right time [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/UNFS8902.Export Citation (RIS)
Publication History
Financial Disclosures
- Ann Ager has no commercial/financial relationships to disclose.
Other Talks in the Series: The Immune System - Key Concepts and Questions
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, my name is Ann Ager.
I'm a professor of immunology in the Division of Infection & Immunity at Cardiff University.
Cardiff is the capital of Wales,
which is part of the United Kingdom.
Today I want to tell you about how lymphocytes move
around our bodies in order to protect us mainly from infection.
The title of my talk is Lymphocyte Homing,
getting lymphocytes to the right place at the right time.
0:31
I'm going to start by giving a couple of slides
just to introduce and give an overview of,
a very short overview of how the immune system works,
and then I'll talk about how lymphocyte homing fits into that.
Then I'll talk about the relevance of this to controlling cancer growth and autoimmunity.
0:53
This is the problem as it were.
How would you start off an immune response to an infection?
Let's use influenza infection of the lungs.
I'm sure a lot of you in the audience will be familiar with
this virus infection and the effects it can have on our bodies.
The frequency of naive lymphocytes with a receptor,
for example, to influenza virus, is very low.
We are born with a full complement of lymphocytes,
but every Lymphocyte has a unique receptor and it's either T cell receptor on T cells or
B cell receptor on B cells which
recognizes a single epitope or an epitope in an and antigen.
But the frequency is very low,
only one in 100,000.
So naive T-cells must survey the antigen-presenting cells,
which presents the epitopes.
In the case of T cells,
this is a peptide MHC complex on the surface of the dendritic cell.
Naive T cells must survey these antigen-presenting cells in order to engage
peptide MHC to become activated to actually initiate either a T cell response,
a cellular response or a B cell,
a humoral or antibody-dependent immune response in order to clear infection.
Naive B cells, like T cells,
have the frequency of naive B cells,
but this specific receptor is very low and they have to encounter
activated T cells to initiate a T cell dependent antibody response,
and by that I mean a class which response from IgM switch response to IgG, IgA and IgE.
Lymphocyte homing solves this problem by bringing together naive T cells,
naive B cells and antigen-presenting cells,
and they all meet up with each other in the secondary lymphoid organs,
ie, the lymph nodes and spleen.
Hide